Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Brian J Scott

Stanford University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (10)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (6)

Crystal L. Mackall

Stanford University School of Medicine

UNITED STATES

View details

Michael Iv

Clinical Professor

Stanford University

UNITED STATES

View details

Surbhi Sidana

Assistant Professor

Stanford University

UNITED STATES

View details

Seema Nagpal

UNITED STATES

View details

Ronda Lun

Assistant Professor

University of Calgary

CANADA

View details

Otto Hannes Vogel

Professor of Pathology and Associate Chair for Neuropathology

Stanford University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Brian J Scott

Research Interests

Explore related searches

Articles (10)

Prevalence of patent foramen ovale in solid organ cancer patients with embolic stroke – A case series

Peripheral Nerve Infiltration by CAR T-cells in a Case of Mononeuritis Multiplex after Ciltacabtagene Autoleucel.

Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.

Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANS.

Immunotherapies for Central Nervous System Tumors and their Neurologic Complications.

EVALUATION OF B7-H3 IMMUNOHISTOCHEMISTRY IN HIGH-GRADE GLIOMAS FOR CHIMERIC ANTIGEN RECEPTOR T-CELL PREDICTIVE TESTING

SINGLE-CELL LANDSCAPE OF B7H3-CAR T THERAPY IN GLIOMA: MECHANISMS OF RESISTANCE AND SIGNATURES OF LONG-TERM RESPONSE

A phase 1 study of B7H3 CAR-T cells administered intracranially in recurrent glioblastoma.

Neurotoxicity in central nervous system tumors treated with CAR T cell therapy: a review.

Cellular immunotherapies for central nervous system cancers.

Collaborators (6)

Crystal L. Mackall

Michael Iv

Surbhi Sidana

Seema Nagpal

Ronda Lun

Otto Hannes Vogel

Make your next move.